ConductScience.org, home

Paper36916933

The Dual Benefit of Sulfasalazine on Pneumocystis Pneumonia-Related Immunopathogenesis and Antifungal Host Defense Does Not Require IL-4Rα-Dependent Macrophage Polarization.

Zhang ZQ and 2 others. Infect Immun, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. The Dual Benefit of Sulfasalazine on Pneumocystis Pneumonia-Related Immunopathogenesis and Antifungal Host Defense Does Not Require IL-4Rα-Dependent Macrophage Polarization. Papers, record 36916933. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36916933

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Dual Benefit of Sulfasalazine on Pneumocystis Pneumonia-Related Immunopathogenesis and Antifungal Host Defense Does Not Require IL-4Rα-Dependent Macrophage Polarization.
PubMed
Journal
Infect Immun
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.53
iCite
Revised in PubMed
2023-09-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang ZQZhuo-Qian
2Gigliotti FFrancis
3Wright TWTerry Whttps://orcid.org/0000-0001-6531-2214

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pneumonia, PneumocystisMajor topic
PneumocystisMajor topic
Mice
Animals
Sulfasalazine
Antifungal Agents
Macrophages
Macrophages, Alveolar

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI117288NIAID NIH HHSUnited StatesR01AI117288PubMed and NIHNIH RePORTER
R01 AI146035NIAID NIH HHSUnited StatesR01AI146035PubMed and NIHNIH RePORTER
R01 HL113495NHLBI NIH HHSUnited StatesR01HL113495PubMed and NIHNIH RePORTER

Download CSV of grants

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112874234Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody.J Immunol2003https://conductscience.org/library/papers/12874234PubMed
29872630Lymphocytes in host defense against Pneumocystis carinii.Semin Respir Infect1998https://conductscience.org/library/papers/9872630PubMed
32049039Mechanisms and modulation of macrophage activation.Behring Inst Mitt1991https://conductscience.org/library/papers/2049039PubMed
415824083Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma.J Exp Med2005https://conductscience.org/library/papers/15824083PubMed
527855071
High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
Antimicrob Agents Chemother2017https://conductscience.org/library/papers/27855071PubMed
612920251IL-4 receptor signaling is required for mannose receptor expression by macrophages recruited to granulomata but not resident cells in mice infected with Schistosoma mansoni.Lab Invest2003https://conductscience.org/library/papers/12920251PubMed
719706447Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19706447PubMed
810545529Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia.J Clin Invest1999https://conductscience.org/library/papers/10545529PubMed
91540135Inhibition of folate-dependent enzymes by non-steroidal anti-inflammatory drugs.Biochem J1992https://conductscience.org/library/papers/1540135PubMed
1032500040Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis.Front Cell Infect Microbiol2020https://conductscience.org/library/papers/32500040PubMed
117911424Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma.Eur J Immunol1994https://conductscience.org/library/papers/7911424PubMed
1217145890p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance.Cancer Res2006https://conductscience.org/library/papers/17145890PubMed
139143691Nitric oxide and macrophage function.Annu Rev Immunol1997https://conductscience.org/library/papers/9143691PubMed
1411159965Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia.Infect Immun2001https://conductscience.org/library/papers/11159965PubMed
159802878Regulation of an essential innate immune response by the p50 subunit of NF-kappaB.J Clin Invest1998https://conductscience.org/library/papers/9802878PubMed
1629652202Effect of sulfasalazine use on the presence of Pneumocystis organisms in the lung among patients with rheumatoid arthritis: A test-negative design case-control study with PCR tests.Mod Rheumatol2019https://conductscience.org/library/papers/29652202PubMed
1721220696IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina.J Immunol2011https://conductscience.org/library/papers/21220696PubMed
1817681149PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties.Cell Metab2007https://conductscience.org/library/papers/17681149PubMed
1930658203Novel dihydropteroate synthase gene mutation in Pneumocystis jirovecii among HIV-infected patients in India: Putative association with drug resistance and mortality.J Glob Antimicrob Resist2019https://conductscience.org/library/papers/30658203PubMed
201613462Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation.J Exp Med1992https://conductscience.org/library/papers/1613462PubMed

See all 60 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
40474676Fungal β-glucan instructed miR-32-5p modulates Dectin-1 signaling mediated inflammation, reactive oxygen species and apoptosis through polarization of "M2a-like" macrophage in Candida colitis.Virulence2025https://conductscience.org/library/papers/40474676PubMed
39150267Protective innate immunity against Pneumocystis does not require Stat6-dependent macrophage polarization.Infect Immun2024https://conductscience.org/library/papers/39150267PubMed
37721419IFN-γ Limits Immunopathogenesis but Delays Fungal Clearance during Pneumocystis Pneumonia.J Immunol2023https://conductscience.org/library/papers/37721419PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36916933

GET https://conductscience.org/api/papers/v1/36916933/references?page=2